Indefinite Delivery Contract SPE2DX15D9533

This single-award Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.99 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of branded and generic pharmaceutical products, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, has an ultimate completion date of November 12, 2025.

The IDC enables the DLA to issue firm fixed-price delivery orders for a diverse array of pharmaceutical items, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain and providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure these federal awards across multiple product categories and medical domains.